NEJM Editorialists: Sentinel System Feasible, But Presents Challenges
This article was originally published in The Gray Sheet
Executive Summary
FDA's post-market surveillance Sentinel Initiative comes with some steep challenges, several health policy experts write in the New England Journal of Medicine July 27